PRINCIPAL FINANCIAL GROUP INC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1126328 DES MOINES, IA

Position in ARQT

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,815,617

+$838,078 QoQ

Shares Held

183,662

+8.8% QoQ

Ownership

0.146%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 271 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. ARQT ranks #47 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,815,617	183,662	+8.8%	Shares	Defined	2026-08-04
2026-03-31	$3,977,539	168,826	+809.9%	Shares	Defined	2026-05-04
2024-06-30	$172,560	18,555	-3.0%	Shares	Defined	2024-07-29
2024-03-31	$189,528	19,125	+3.8%	Shares	Defined	2024-04-29
2023-12-31	$59,496	18,420	+22.1%	Shares	Defined	2024-02-07
2023-09-30	$80,095	15,084	+1.0%	Shares	Defined	2023-11-02
2023-06-30	$142,339	14,936	+11.6%	Shares	Defined	2023-08-07
2023-03-31	$147,213	13,383	-6.8%	Shares	Defined	2023-05-09
2022-12-31	$212,557	14,362	+22.7%	Shares	Defined	2023-02-09
2022-09-30	$223,739	11,708	+5.6%	Shares	Defined	2022-11-09
2022-06-30	$236,263	11,087	+11.4%	Shares	Defined	2022-08-10
2021-09-30	$237,729	9,951	-13.9%	Shares	Defined	2021-11-09
2021-06-30	$315,526	11,562	—	Shares	Defined	2021-08-10
No filing history on record for this holder in this stock.